Detected ·
Oyster Therapeutics
£45MSeries A
Oyster Therapeutics secures a £45m Series A round from CE Ventures (CEIIF) to develop an oral drug for neurodegenerative diseases.
- Website
- —
- linkedin.com/company/98348645
- Amount
- £45 000 000 GBP
- Stage
- Series A
- Event
- Funding round
- Detected
- 2026-11-14 04:15:12 UTC
- Signal ID
- a64d8088-32db-45ec-99b8-88ea85a3a70a
As the API returns it
{
"id": "a64d8088-32db-45ec-99b8-88ea85a3a70a",
"created_at": "2026-11-14T04:15:12.184944Z",
"company_name": "Oyster Therapeutics",
"company_website_url": null,
"company_linkedin_url": "https://www.linkedin.com/company/98348645",
"event_type": "funding",
"funding_amount": 45000000,
"funding_currency": "GBP",
"funding_stage": "series_a",
"message": "*Oyster Therapeutics secures a £45m Series A round from CE Ventures (CEIIF) to develop an oral drug for neurodegenerative diseases.*"
}